Cancer Patient’s Deadly Brain Tumor Disappeared After Taking Experimental New Drug – Def-Con News

0
290

A groundbreaking case out of the United Kingdom is bringing hope to those battling glioblastoma, one of the deadliest forms of brain cancer.

Ben Trotman, diagnosed in 2022 at the age of 40, is now living without any signs of cancer more than two years after receiving an experimental new treatment.

This from slaynews.com.

Trotman revealed he went from being perfectly healthy to being given just months to live, to being completely cancer-free again.

Glioblastoma is notorious for its aggressiveness. Patients typically survive just 15 months after diagnosis. The survival rate over five years is a mere 6.9%. However, Trotman, whose prognosis initially seemed grim, has defied the odds, thanks to an experimental immunotherapy drug.

Trotman’s…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here